Deutsche Bank’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-140
| Closed | -$7K | – | 4041 |
|
|
2021
Q3 | $7K | Hold |
140
| – | – | ﹤0.01% | 4127 |
|
|
2021
Q2 | $8K | Sell |
140
-1,239
| -90% | -$70.8K | ﹤0.01% | 4296 |
|
|
2021
Q1 | $79K | Sell |
1,379
-38
| -3% | -$2.18K | ﹤0.01% | 4014 |
|
|
2020
Q4 | $96K | Buy |
1,417
+371
| +35% | +$25.1K | ﹤0.01% | 3784 |
|
|
2020
Q3 | $265K | Buy |
1,046
+137
| +15% | +$34.7K | ﹤0.01% | 3020 |
|
|
2020
Q2 | $153K | Buy |
+909
| New | +$153K | ﹤0.01% | 3208 |
|
|
2020
Q1 | – | Sell |
-235
| Closed | -$15K | – | 4128 |
|
|
2019
Q4 | $15K | Buy |
+235
| New | +$15K | ﹤0.01% | 4190 |
|
|
2018
Q2 | – | Sell |
-1,994
| Closed | -$94K | – | 4892 |
|
|
2018
Q1 | $94K | Sell |
1,994
-4,579
| -70% | -$216K | ﹤0.01% | 4330 |
|
|
2017
Q4 | $386K | Buy |
6,573
+5,045
| +330% | +$296K | ﹤0.01% | 3632 |
|
|
2017
Q3 | $94K | Buy |
+1,528
| New | +$94K | ﹤0.01% | 3981 |
|